862501-91-5 Usage
Description
Methyl 4-(((benzyloxy)carbonyl)amino)bicyclo[2.2.2]octane-1-carboxylate is a complex chemical compound characterized by a bicyclic ring system and a benzyloxy carbonyl group. It is recognized for its potential as a building block in the synthesis of new drugs and medicinally active molecules, with a focus on its unique structural features and pharmacological properties that make it a promising candidate for further investigation in medicinal chemistry.
Uses
Used in Pharmaceutical Research and Development:
Methyl 4-(((benzyloxy)carbonyl)amino)bicyclo[2.2.2]octane-1-carboxylate is utilized as a key intermediate in the synthesis of novel drugs and medicinally active molecules. Its unique structure allows for the development of compounds with enhanced biological activity and therapeutic potential.
Used in Medicinal Chemistry:
In the field of medicinal chemistry, this compound is employed as a target for the exploration of its potential biological activity. Its ability to interact with receptors or enzymes in the body is of particular interest, as it may lead to the discovery of new treatments for various diseases and conditions.
Used in Drug Design and Optimization:
Methyl 4-(((benzyloxy)carbonyl)amino)bicyclo[2.2.2]octane-1-carboxylate is used as a structural component in drug design and optimization processes. Its incorporation into new molecular entities can contribute to improved pharmacokinetic and pharmacodynamic profiles, ultimately resulting in more effective and safer medications.
Check Digit Verification of cas no
The CAS Registry Mumber 862501-91-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,6,2,5,0 and 1 respectively; the second part has 2 digits, 9 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 862501-91:
(8*8)+(7*6)+(6*2)+(5*5)+(4*0)+(3*1)+(2*9)+(1*1)=165
165 % 10 = 5
So 862501-91-5 is a valid CAS Registry Number.
862501-91-5Relevant articles and documents
2,3-DIHYDRO-1H-PYRROLIZINE-7-FORMAMIDE DERIVATIVE AND APPLICATION THEREOF
-
Paragraph 0293; 0294; 0295; 0296, (2021/04/16)
The present application relates to a 2,3-dihydro-1H-pyrrolizine-7-formamide derivative as a nucleoprotein inhibitor and a use in preparation of a drug for treating HBV related diseases. The present application specifically relates to a compound represented by formula (II), and isomers or pharmaceutically acceptable salts thereof.
NOVEL AMIDE AND AMIDINE DERIVATIVES AND USES THEREOF
-
Page/Page column 32, (2010/11/03)
The present invention relates to inhibitors of 11-β-hydroxysteroid dehydrogenase type 1 enzyme and their use in treatment of non-insulin dependent type 2 diabetes, insulin resistance, obesity, lipid disorders, metabolic syndrome, central nervous system disorders, and diseases and conditions that are related to excessive glucocorticoids.
BICYCLO DERIVATIVE
-
Page/Page column 7, (2008/06/13)
A novel bicyclo derivative represented by the following general formula (1), or a pharmaceutically acceptable salt thereof, acts as an effective DPP-IV inhibitor: One example is (2S,4S)-1-[[N-(4-methylbicyclo[2.2.2]oct-1-yl)amino]acetyl]-4-fluoropyrrolidi
